“What is an investigational new drug?”

Funding News Edition: August 03, 2022
See more articles in this edition

The term investigational new drug (IND) refers to a drug or biological product that will be or is being used in a clinical investigation, having already been tested in a laboratory and approved by the FDA for use in humans in a research setting following successful submission and review of an Investigational New Drug Application.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on